# Armour Residential REIT, Inc.: financial statements, quarterly

ARR · NYSE · CIK 1428205 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/arr.md) · [Financials](/companies/arr/financials.md) · [Filings](/companies/arr/filings.md) · [Insiders](/companies/arr/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/arr/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $m | [99.6 d](/filings/0001428205-26-000029.md) | [14.5](/filings/0001428205-25-000090.md) | [(48.4)](/filings/0001428205-25-000161.md) | [65.9](/filings/0001428205-25-000233.md) | [(46.4) d](/filings/0001428205-26-000029.md) | [27.3](/filings/0001428205-26-000059.md) | [(75.6)](/filings/0001428205-26-000090.md) | [159](/filings/0001428205-26-000125.md) | [212 d](/filings/0001428205-26-000029.md) | [(54.9)](/filings/0001428205-26-000059.md) | [115](/filings/0001428205-26-000090.md) | [(324)](/filings/0001428205-26-000125.md) |
| Diluted EPS | $ per share | not reported | [0.24](/filings/0001428205-25-000090.md) | [(1.05)](/filings/0001428205-25-000161.md) | [1.21](/filings/0001428205-25-000233.md) | not reported | [0.32](/filings/0001428205-26-000059.md) | [(0.94)](/filings/0001428205-26-000090.md) | [1.49](/filings/0001428205-26-000125.md) | not reported | [(0.49)](/filings/0001428205-26-000059.md) | [0.86](/filings/0001428205-26-000090.md) | [(2.26)](/filings/0001428205-26-000125.md) |
| Basic EPS | $ per share | not reported | [0.24](/filings/0001428205-25-000090.md) | [(1.05)](/filings/0001428205-25-000161.md) | [1.22](/filings/0001428205-25-000233.md) | not reported | [0.32](/filings/0001428205-26-000059.md) | [(0.94)](/filings/0001428205-26-000090.md) | [1.50](/filings/0001428205-26-000125.md) | not reported | [(0.49)](/filings/0001428205-26-000059.md) | [0.86](/filings/0001428205-26-000090.md) | [(2.26)](/filings/0001428205-26-000125.md) |

- Revenue: not reported
- Interest expense: not reported
- Income tax: not reported
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.2](/filings/0001428205-25-000027.md) | [0.2](/filings/0001428205-24-000100.md) | [0.1](/filings/0001428205-24-000182.md) | [0.1](/filings/0001428205-24-000235.md) | [0.1](/filings/0001428205-26-000029.md) | [0.0](/filings/0001428205-25-000090.md) | [0.1](/filings/0001428205-25-000161.md) | [0.0](/filings/0001428205-25-000233.md) | [0.1](/filings/0001428205-26-000125.md) | [0.1](/filings/0001428205-26-000059.md) | [0.1](/filings/0001428205-26-000090.md) | [0.1](/filings/0001428205-26-000125.md) |
| Total assets | $bn | [12.3](/filings/0001428205-25-000027.md) | [12.2](/filings/0001428205-24-000100.md) | [10.1](/filings/0001428205-24-000182.md) | [13.4](/filings/0001428205-24-000235.md) | [13.5](/filings/0001428205-26-000029.md) | [15.5](/filings/0001428205-25-000090.md) | [16.2](/filings/0001428205-25-000161.md) | [19.4](/filings/0001428205-25-000233.md) | [21.0](/filings/0001428205-26-000125.md) | [21.5](/filings/0001428205-26-000059.md) | [22.7](/filings/0001428205-26-000090.md) | [22.5](/filings/0001428205-26-000125.md) |
| Total liabilities | $bn | [11.1](/filings/0001428205-25-000027.md) | [11.0](/filings/0001428205-24-000100.md) | [8.9](/filings/0001428205-24-000182.md) | [12.1](/filings/0001428205-24-000235.md) | [12.2](/filings/0001428205-26-000029.md) | [13.8](/filings/0001428205-25-000090.md) | [14.6](/filings/0001428205-25-000161.md) | [17.2](/filings/0001428205-25-000233.md) | [18.7](/filings/0001428205-26-000125.md) | [19.1](/filings/0001428205-26-000059.md) | [20.2](/filings/0001428205-26-000090.md) | [20.1](/filings/0001428205-26-000125.md) |
| Shareholders' equity | $bn | [1.3](/filings/0001428205-26-000029.md) | [1.2](/filings/0001428205-25-000161.md) | [1.2](/filings/0001428205-25-000233.md) | [1.3](/filings/0001428205-25-000233.md) | [1.4](/filings/0001428205-26-000125.md) | [1.7](/filings/0001428205-26-000090.md) | [1.7](/filings/0001428205-26-000125.md) | [2.1](/filings/0001428205-26-000125.md) | [2.3](/filings/0001428205-26-000125.md) | [2.3](/filings/0001428205-26-000090.md) | [2.6](/filings/0001428205-26-000125.md) | [2.4](/filings/0001428205-26-000125.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [60.3 d](/filings/0001428205-26-000029.md) | [96.8](/filings/0001428205-25-000090.md) | [27.1 d](/filings/0001428205-25-000161.md) | [47.1 d](/filings/0001428205-25-000233.md) | [90.4 d](/filings/0001428205-26-000029.md) | [101](/filings/0001428205-26-000059.md) | [25.0 d](/filings/0001428205-26-000090.md) | [(37.8) d](/filings/0001428205-26-000125.md) | [35.6 d](/filings/0001428205-26-000029.md) | [112](/filings/0001428205-26-000059.md) | [210 d](/filings/0001428205-26-000090.md) | [98.9 d](/filings/0001428205-26-000125.md) |
| Dividends paid | $m | [59.0 d](/filings/0001428205-26-000029.md) | [35.3](/filings/0001428205-25-000090.md) | [38.3](/filings/0001428205-25-000161.md) | [40.5](/filings/0001428205-25-000233.md) | [42.9 d](/filings/0001428205-26-000029.md) | [54.1](/filings/0001428205-26-000059.md) | [63.4](/filings/0001428205-26-000090.md) | [79.2](/filings/0001428205-26-000125.md) | [80.7 d](/filings/0001428205-26-000029.md) | [86.3](/filings/0001428205-26-000059.md) | [96.4](/filings/0001428205-26-000090.md) | [109](/filings/0001428205-26-000125.md) |
| Share repurchases | $m | [3.6 d](/filings/0001428205-26-000029.md) | [1.3](/filings/0001428205-25-000090.md) | [0.0 d](/filings/0001428205-25-000161.md) | [0.0 d](/filings/0001428205-25-000233.md) | [0.0 d](/filings/0001428205-26-000029.md) | [0.0](/filings/0001428205-26-000059.md) | [10.0 d](/filings/0001428205-26-000090.md) | [9.9 d](/filings/0001428205-26-000125.md) | [0.0 d](/filings/0001428205-26-000029.md) | [2.0](/filings/0001428205-26-000059.md) | [0.0 d](/filings/0001428205-26-000090.md) | [5.1 d](/filings/0001428205-26-000125.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock, us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [36.9](/filings/0001428205-24-000100.md) | [40.1](/filings/0001428205-24-000182.md) | [46.5](/filings/0001428205-24-000235.md) | [49.0](/filings/0001428205-25-000090.md) | [48.8](/filings/0001428205-25-000161.md) | [51.8](/filings/0001428205-25-000233.md) | [75.4](/filings/0001428205-26-000059.md) | [83.8](/filings/0001428205-26-000090.md) | [105](/filings/0001428205-26-000125.md) | [120](/filings/0001428205-26-000059.md) | [130](/filings/0001428205-26-000090.md) | [145](/filings/0001428205-26-000125.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 148,415,420 at 2026-10-20, from the cover of the [10-Q filed 2026-10-21](/filings/0001428205-26-000125.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:39 ET. No prices; not investment advice.